Chief Executive Officer

Physio mics

Physio mics plc (AIM: PYC) is an Oxford-based contract research organisation and consultancy specialising in the application of mathematical and data science solutions to support the development of therapeutic drugs and personalised medicine dosing software. Physio mics has a current turnover of circa £1m p.a. It has a high‑profile brand and an established customer base of clients in the UK, Europe and North America.

Physio mics takes a collaborative approach to provide clients with bespoke solutions encompassing data, analytics and insight.

Physio mics is structured in two service‑lines;
Model Informed Drug Development (MIDD) and Biometrics.

The Company’s MIDD service‑line provides a full range of pharmacokinetic/pharmacodynamic contract services to companies ranging from biotechs to some of the largest pharmaceutical companies in the world, across multiple therapeutic areas. The Company uses a range of commercially available software solutions but also maintains its own proprietary Virtual Tumour™ model which simulates the effects of anti‑cancer agents on pre‑clinical and human tumours, helping clients to improve the success rate of drug discovery and development projects while reducing time and cost.

The MIDD service‑line has completed over 140 commercial projects, involving over 125 targets and drugs, and has worked with clients such as Merck KGaA, Numab Therapeutics, Cancer Research UK and Bicycle Therapeutics, to name but a few.

The Company recently expanded its contract services into the field of Biometrics, which is run as a separate service‑line and provides biostatistics, statistical programming and data management solutions. Even though only recently launched, this service‑line is already delivering on several client contracts and has a rapidly growing pipeline of opportunities being progressed.

Separately from its contract services business, Physio mics has won several Innovate UK and NIHR grants which it has used to develop a software tool to personalise the dose of chemotherapy. It has an ongoing collaboration with US company, Dose Me, and has incorporated this tool into their existing commercial platform (Dose Me Rx ). The dosing software tool is currently available for research use only, but as the tool is further developed, the plan is to implement paid for functionality.

Physio mics is seeking a new leader to drive an ambitious program of expansion and strategic change within an LSE AIM‑listed business. The role requires excellent influencing skills, keen commercial acumen and the ability to communicate effectively with both scientific/ clinical and commercial stakeholders.

Even though prior experience is not necessary, the role will be responsible for managing all corporate activities pertaining to being a public company, work with the board of directors, Company Secretary, NOMAD and Broker to ensure compliance to AIM rules and effective governance of the business.

Physio mics’ revenues are derived mostly from its core contract services business, and this will remain the first priority of the incoming CEO who will be able to support the acquisition and retention of clients, participate in key meetings and presentations, lead the internal team and have the experience and gravitas to act as a senior advisor to key client contacts.

The Company currently operates virtually, although the CEO will need to be available for regular face‑to‑face team meetings in the Oxford / London area. The role will require occasional travel (in the UK and abroad) to clients, networking activities, and meetings with stakeholders. The company currently has 12 permanent employees (including Board Directors) and utilises contractors to provide additional capacity and expertise when required.

The Company operates a fee for service revenue model but has developed a personalised dosing tool that could form the basis of a software‑as‑a‑service offering.

Physio mics believes this role represents a real opportunity for the right individual to make a significant impact in a small organisation.

Operational

• Set the Company’s overall strategy, balancing core consulting…